Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019158 (hepatitis)
 30,205 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

5-Nucleotidase (5-Nase) was determined in the serum of 67 Egyptian Children: 15 cases as a control group, 10 cases with infantile rickets, 8 cases with the so-called physiological jaundice of the newborn, 4 cases with rhesus incompatibility, and 30 cases with infective hepatits. In rachitic cases and in cases with icterus neonatorum, 5-Nase was not increased, while in cases with infective hepatitis it showed a statistically significant elevation when compared with the control group.
 ...
PMID:Serum 5-nucleotidase in some rachitic and jaundiced Egyptian children. 103 71

Infantile hepatitis syndrome is a liver disease which occurs during the infantile period with the clinical manifestation of jaundice, haptomegaly, and liver dysfunction. The cause of the disease is complex, and, currently, no medicine can provide satisfactory treatment. Yinzhihuang injectable has been found to be effective in treating infantile jaundice, and acute and chronic hepatitis and, therefore, its effectiveness in treating infantile hepatitis syndrome was tested. From March 1987 to June 1988, 55 infants with hepatitis syndrome were treated with Yinzhihuang injection for 1 or 2 15-day cycles, and 15 infants randomly chosen to be the controls received injections of Inosine, vitamin C, and glucose. Serum bilirubin level, liver SALT levels, duodenal juice bilirubin level, liver size, and T cell subsets in peripheral blood were tested both before and after the treatment. The results showed that the treatment group experiences a significant decline of serum bilirubin level and a reduction in liver size after the treatment, while the differences for the control group were not significant. The duodenal juice bilirubin level of the treatment group increased, but the difference was not statistically significant. Both the treatment and the control group experienced a reduction of CD+4 to normal level, but CD+8 for both groups was still high, which indicated that Yinzhihuang can not regulate cell immunological functioning in a short term. Nevertheless, its longterm impact on immunological functions needs to be further explored.
 ...
PMID:[Treatment of infantile hepatitis syndrome with injection of yin zhi huang]. 132 Sep 65

We reviewed the laboratory parameters, clinical information including presence or absence of stool pigmentation, and ultrasonographic findings in 67 patients with neonatal conjugated hyperbilirubinemia and liver biopsies. Hepatobiliary nuclear scintigraphy was done in 14 of the patients. Final diagnoses included extrahepatic biliary atresia, neonatal hepatitis, cystic fibrosis, metabolic liver disease, alpha 1-antitrypsin deficiency, bile duct stenosis, Alagille syndrome (arteriohepatic dysplasia), choledochal cyst, panhypopituitarism, and miscellaneous causes of intrahepatic cholestasis. A single diagnostic criterion is insufficient to distinguish the various causes of neonatal jaundice. Clinical laboratory values varied widely among patients with medical and surgical causes of jaundice. Absence of stool pigmentation was not specific for biliary atresia and was found in patients with medical causes of jaundice. Conversely, two patients with biliary atresia had pigmented stools at presentation. Ultrasonography was diagnostic only for choledochal cyst and bile duct stenosis. Nonvisualization of the gallbladder by either ultrasonography or nuclear hepatobiliary scintigraphy was nonspecific in the discrimination of medical from surgical causes of jaundice. A multidisciplinary approach to the evaluation of neonatal jaundice is necessary, since no single test or imaging modality can reliably define the cause in all cases.
 ...
PMID:Neonatal jaundice: clinical and ultrasonographic findings. 218 86

Fifteen patients with persistent neonatal jaundice were evaluated by sonography and radionuclide scintigraphy. The sonographic features of both neonatal hepatitis and biliary atresia are nonspecific. Hepatobiliary scintigraphy after phenobarbital pretreatment in patients with neonatal hepatitis demonstrates normal hepatic extraction and delayed tracer excretion into the gastrointestinal tract. If there is neonatal hepatitis with severe hepatocellular damage, the hepatic extraction of tracer activity is decreased and excretion may be delayed or absent. Patients under 3 months of age with biliary atresia have normal hepatic extraction of tracer with no excretion into the gastrointestinal tract. Sonography in patients with a choledochal cyst shows a cystic mass in the porta hepatis with associated bile-duct dilatation. Hepatobiliary scintigraphy confirms that the choledochal cyst communicates with the biliary system. Initial sonography demonstrates hepatobiliary anatomy; subsequent phenobarbital-enhanced radionuclide scintigraphy determines hepatobiliary function. An expedient diagnostic approach is recommended for the evaluation of persistent neonatal jaundice.
 ...
PMID:An imaging approach to persistent neonatal jaundice. 660 24

Hepatobiliary scintigraphy with technetium 99m-labeled p-isopropylacetanilido iminodiacetic acid (99mTc-PIPIDA) was used to evaluate 22 neonates with mixed jaundice. Ten patients were proved to have biliary atresia; ten others were diagnosed as having neonatal hepatitis. In the remaining two, jaundice was secondary to prolonged hyperalimentation. Initial studies in all ten patients with biliary atresia showed no evidence of excretion of the tracer into the intestinal tract. Following three to seven days of oral administration of phenobarbital, repeat studies were performed in six of the ten patients. None showed evidence of excretion. Initial studies of the 12 patients with intrahepatic cholestasis showed definite excretion in five, questionable evidence of excretion in two, and no demonstrable excretion in five. Studies after phenobarbital therapy in five of the seven patients with questionable or no excretion on the initial studies showed definite excretion in four. Only in one patient who had poor hepatic extraction did the phenobarbital therapy not change the scintigraphic pattern. The authors conclude that hepatobiliary scintigraphy with 99mTc-PIPIDA after three to seven days of phenobarbital therapy is a highly accurate test for differentiating biliary atresia from other causes of neonatal jaundice.
 ...
PMID:Hepatobiliary scintigraphy with 99mTc-PIPIDA in the evaluation of neonatal jaundice. 678 55

A problem-orientated case record was used for the investigation and management of neonatal jaundice. Investigation of babies requiring phototherapy rarely showed any abnormality but we consider that such routine investigations are worth retaining. There were problems in the interpretation of moderately low plasma concentrations of thyroxine in small, preterm babies. There was biochemical evidence of hepatitis in 3 babies; in all 3 the biochemical abnormality was mild and had disappeared 6 months later in 2 of them. It may be that mild episodes of the neonatal hepatitis syndrome are more common than have been thought and that such infants have a fairly good prognosis.
 ...
PMID:Investigation and management of neonatal jaundice: a problem-orientated case record. 697 40

There is good evidence that neonatal hepatitis, biliary hypoplasia, biliary atresia and choledochal cyst are different stages of one disease process for which the term infantile obstructive cholangiopathy has been suggested. Thanks to the work of Kasai and the operation of hepatic portoenterostomy the surgical outlook has greatly improved, although in North America it still leaves much to be desired. One cannot procrastinate too long in the hope that the patient's condition will improve spontaneously, because the surgical results are much better when the operation is performed before the patient is 10 weeks old. This article outlines the steps that should be followed in investigating neonatal jaundice, the nonsurgical measures that can be taken in an attempt to reverse or alleviate the underlying condition, and the specific role of the pediatric surgeon in the management of choledochal cyst and biliary atresia.
 ...
PMID:Neonatal jaundice: the surgical viewpoint. 700 74

Neonatal hepatitis and biliary atresia are disorders of early infancy that represent variable expressions of one entity. Clinical and extensive laboratory evaluation are unsatisfactory in distinguishing between the two diseases. The usefulness of hepatobiliary ultrasonography in the evaluation of neonatal jaundice is described in four infants. Ultrasonic diagnosis was substantiated by laparotomy, liver biopsy or autopsy. The performance of hepatobiliary ultrasonography is recommended in all cases of neonatal jaundice in order to differentiate between extrahepatic biliary obstruction and neonatal hepatitis.
 ...
PMID:Hepatobiliary ultrasonography as a diagnostic aid in neonatal jaundice. 714 55

The case histories of three boys with a micropenis, abnormal facial features and congenital hypopituitarism are described. Two of the boys in addition had congenital deformities of the feet. A prolonged neonatal jaundice or a neonatal hepatitis, and an abnormal mental development was also found. This complicated syndrome is caused by impaired development of the prosencephalon. The ensuing anatomical changes have been called holoprosencephaly. Early recognition of this syndrome rests on the micropenis and the abnormal facial features.
 ...
PMID:[Congenital functional disorders of the hypothalamus caused by a development disorder of the prosencephalon]. 726 57

Hepatobiliary scintigraphy with 99mTc-IDA derivatives was used to evaluate 40 neonates with mixed jaundice. Fourteen patients proved to have biliary atresia. The remaining 26 patients had intrahepatic cholestasis with patent extrahepatic ducts. Sixteen of the 40 patients underwent examinations without phenobarbital stimulation. Sixteen patients had two examinations, one before and one after 3-7 days of phenobarbital therapy. The remaining 8 patients had their initial examinations after phenobarbital therapy. The results of this study show that administration of phenobarbital in a dose of 5 mg/kg/day for at least 5 days prior to the examination enhances and accelerates biliary excretion of IDA compounds and thereby significantly increases the accuracy of 99mTc-IDA scintigraphy in differentiating extrahepatic biliary atresia from neonatal hepatitis. Its routine use in the evaluation of neonatal jaundice is therefore highly recommended.
 ...
PMID:Effect of phenobarbital on 99mTc-IDA scintigraphy in the evaluation of neonatal jaundice. 728 Jul 2


1 2 3 Next >>